Bessemer Group’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-162
| Closed | -$40K | – | 2206 |
|
|
2022
Q3 | $40K | Buy |
162
+31
| +24% | +$8.37K | ﹤0.01% | 1222 |
|
|
2022
Q2 | $32K | Sell |
131
-126
| -49% | -$34K | ﹤0.01% | 1175 |
|
|
2022
Q1 | $86K | Buy |
257
+74
| +40% | +$22.8K | ﹤0.01% | 992 |
|
|
2021
Q4 | $66K | Sell |
183
-297
| -62% | -$100K | ﹤0.01% | 1074 |
|
|
2021
Q3 | $156K | Buy |
480
+316
| +193% | +$107K | ﹤0.01% | 842 |
|
|
2021
Q2 | $52K | Sell |
164
-68
| -29% | -$20.9K | ﹤0.01% | 1060 |
|
|
2021
Q1 | $74K | Sell |
232
-186,224
| -100% | -$59.6M | ﹤0.01% | 936 |
|
|
2020
Q4 | $60.4M | Sell |
186,456
-42
| -0% | -$11.6K | 0.16% | 158 |
|
|
2020
Q3 | $51.7M | Buy |
186,498
+33,617
| +22% | +$9.68M | 0.15% | 155 |
|
|
2020
Q2 | $36.9M | Buy |
152,881
+48
| +0% | +$9.64K | 0.12% | 157 |
|
|
2020
Q1 | $22.2M | Hold |
152,833
| – | – | 0.09% | 172 |
|
|
2019
Q4 | $26.1M | Buy |
152,833
+152,605
| +66,932% | +$28.3M | 0.08% | 190 |
|
|
2019
Q3 | $41K | Sell |
228
-147,907
| -100% | -$32M | ﹤0.01% | 1304 |
|
|
2019
Q2 | $38.6M | Buy |
148,135
+148,023
| +132,163% | +$39.3M | 0.13% | 163 |
|
|
2019
Q1 | $32K | Sell |
112
-122
| -52% | -$40.5K | ﹤0.01% | 1358 |
|
|
2018
Q4 | $76K | Buy |
234
+82
| +54% | +$28.5K | ﹤0.01% | 1218 |
|
|
2018
Q3 | $68K | Buy |
+152
| New | +$59.9K | ﹤0.01% | 1209 |
|
|
2018
Q2 | – | Sell |
-179
| Closed | -$52K | – | 1820 |
|
|
2018
Q1 | $52K | Sell |
179
-43
| -19% | -$10.9K | ﹤0.01% | 1232 |
|
|
2017
Q4 | $42K | Hold |
222
| – | – | ﹤0.01% | 1283 |
|
|
2017
Q3 | $37K | Hold |
222
| – | – | ﹤0.01% | 1355 |
|
|
2017
Q2 | $32K | Hold |
222
| – | – | ﹤0.01% | 1390 |
|
|
2017
Q1 | $27K | Sell |
222
-15
| -6% | -$1.74K | ﹤0.01% | 1415 |
|
|
2016
Q4 | $27K | Sell |
237
-9
| -4% | -$1.04K | ﹤0.01% | 1476 |
|
|
2016
Q3 | $32K | Sell |
246
-384
| -61% | -$46K | ﹤0.01% | 1279 |
|
|
2016
Q2 | $69K | Sell |
630
-596
| -49% | -$59.3K | ﹤0.01% | 818 |
|
|
2016
Q1 | $116K | Buy |
1,226
+595
| +94% | +$50.2K | ﹤0.01% | 758 |
|
|
2015
Q4 | $57K | Buy |
631
+15
| +2% | +$1.27K | ﹤0.01% | 943 |
|
|
2015
Q3 | $57K | Buy |
616
+55
| +10% | +$4.85K | ﹤0.01% | 932 |
|
|
2015
Q2 | $37K | Hold |
561
| – | – | ﹤0.01% | 1032 |
|
|
2015
Q1 | $40K | Hold |
561
| – | – | ﹤0.01% | 1010 |
|
|
2014
Q4 | $21K | Hold |
561
| – | – | ﹤0.01% | 1105 |
|
|
2014
Q3 | $14K | Hold |
561
| – | – | ﹤0.01% | 1064 |
|
|
2014
Q2 | $14K | Hold |
561
| – | – | ﹤0.01% | 1065 |
|
|
2014
Q1 | $15K | Hold |
561
| – | – | ﹤0.01% | 1035 |
|
|
2013
Q4 | $15K | Hold |
561
| – | – | ﹤0.01% | 1038 |
|
|
2013
Q3 | $10K | Hold |
561
| – | – | ﹤0.01% | 1038 |
|
|
2013
Q2 | $12K | Buy |
+561
| New | +$11.3K | ﹤0.01% | 1012 |
|
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Bessemer Group's ABMD Position: Q4 2022 in Review
Bessemer Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 162 shares — an estimated $40K sold.
Bessemer Group first reported a position in ABMD in Q2 2013 and held it in 37 quarters. The position peaked at $60.4M in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Bessemer Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Bessemer Group sold 162 Abiomed Inc shares in Q4 2022, an estimated $40K.
- Bessemer Group first reported a position in Abiomed Inc in Q2 2013 and held it in 37 quarters.
- Bessemer Group's Abiomed Inc position peaked at $60.4M in Q4 2020.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Bessemer Group's 13F filing for Q4 2022, filed 13 Feb 2023.